What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson announced a quarterly dividend on Wednesday, January 25th. Investors of record on Wednesday, March 1st will be paid a dividend of $0.28 per share on Monday, April 3rd. This represents a $1.12 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend is Monday, February 27th.
Where is McKesson's stock going? Where will McKesson's stock price be in 2017?
17 analysts have issued twelve-month price objectives for McKesson's shares. Their predictions range from $131.00 to $225.00. On average, they anticipate McKesson's stock price to reach $176.14 in the next twelve months.
When will McKesson announce their earnings?
McKesson is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.
What are analysts saying about McKesson stock?
Here are some recent quotes from research analysts about McKesson stock:
According to Zacks Investment Research, "McKesson depends heavily on the pharmaceutical distribution business, which is characterized by slow growth. Unfavorable movements in foreign exchange rates continue to hurt sales. In addition McKesson expects weaker generic pharmaceutical pricing trends, specific to the company’s mix of business, in 2017. Moreover, the expiration of McKesson’s contract with Optum will be a major headwind. Operating performance of Celesio which was disappointing in the fiscal first quarter of 2017 due to reimbursement cuts, is expected to continue through the year. However, the company has been actively pursuing deals and acquisitions to drive growth. McKesson will separate its Technology business into a new healthcare information technology company, which is slated to close in the first half of calendar 2017. The spin-off will enable the company to concentrate on the primary pharmaceuticals distribution business." (9/29/2016)
FBR & Co analysts commented, "This morning, McKesson announced that it will combine most of its IT businesses with privately owned Change Healthcare (formerly known as Emdeon). MCK will own 70% of the new company and receive cash proceeds of $1.25 billion. MCK will continue to own the Relay Health Pharmacy operations and divest its Enterprise Information Solutions (EIS) division. The new company is expected to complete an IPO in the first half of CY17, and McKesson intends to exit its investment in the new company in a tax-efficient manner. We view the proposed transaction as a solid step to finally exiting the IT business, which the company entered in 1998. However, the ultimate impact on MCK will depend on how the new company is valued in the public equity markets and how MCK redeploys net proceeds from its potential sale." (6/29/2016)
Who owns McKesson stock?
McKesson's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (4.69%), FMR LLC (2.82%), Vulcan Value Partners LLC (1.63%), Scharf Investments LLC (0.49%), Institutional Capital LLC (0.48%) and Baupost Group LLC MA (0.47%). Company insiders that own McKesson stock include Erin M Lampert, James A Beer, John H Hammergren, Jorge Figueredo, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Paul C Julian, Susan R Salka and Wayne A Budd.
Who sold McKesson stock? Who is selling McKesson stock?
McKesson's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Southpoint Capital Advisors LP, Institutional Capital LLC, Franklin Resources Inc., Numeric Investors LLC, Martingale Asset Management L P, Teachers Retirement System of The State of Kentucky and AQR Capital Management LLC. Company insiders that have sold McKesson stock in the last year include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake and Wayne A Budd.
Who bought McKesson stock? Who is buying McKesson stock?
McKesson's stock was purchased by a variety of institutional investors in the last quarter, including Vulcan Value Partners LLC, Baupost Group LLC MA, Glenview Capital Management LLC, State Street Corp, Equity Investment Corp Acquisition Inc, Asset Management One Co. Ltd., Appaloosa LP and Russell Investments Group Ltd.. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka.
How do I buy McKesson stock?
Shares of McKesson can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of McKesson stock cost?
One share of McKesson stock can currently be purchased for approximately $150.85.